Concepedia

Susan O’Brien

SO

Statistics

Publications

42

Citations

4.3K

H-Index

29

Active since

1987

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Susan O’Brien is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and chemotherapy.

Publications per year

1987–2019

42

Publications

42

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

Hagop M. Kantarjian, Susan O’Brien, Farhad Ravandi et al. · Cancer · 2008 · 485 citations · Full text

, , +14

Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia

Guillermo Garcia‐Manero, Hagop M. Kantarjian, Blanca Sánchez‐González et al. · Blood · 2006 · 468 citations · Full text

, , +10

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop M. Kantarjian, Susan O’Brien, Elias Jabbour et al. · Blood · 2012 · 338 citations · Full text

, , +5

Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy

Jennifer A. Woyach, Kelly A. Smucker, Lisa L. Smith et al. · Blood · 2014 · 274 citations · Full text

, , +14

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Jörge E. Cortes, Maher Albitar, Deborah A. Thomas et al. · Blood · 2003 · 209 citations

, , +12

1–5 of 42